Lung Cancer Trials Ask AI to find trials
Active Not RecruitingEarly Phase 1NCT04848961
Official study title

A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer

Study summary

The purpose of this study is to develop a digital strategy to increase awareness about lung cancer screening among women who are eligible to receive it. The digital strategy involves email communications and LungTalk, a web-based (accessed through the Internet) health communication tool that uses text, audio, video, and animation to increase awareness and knowledge about lung cancer screening. This study will focus on women who have recently received a screening mammogram.

Ask AI to explain this study
Start here

Key things to know

Main goalPrevention

This describes the study’s primary purpose.

What is being studiedLungTalk

The study team can explain what participation involves.

Who it may be forSmoking

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 6, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Early Phase 1

Interventional

Where is it offered?7 U.S. locations

Locations may change over time.

Who runs it?Memorial Sloan Kettering Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Early Phase 1
Sponsor
Memorial Sloan Kettering Cancer Center
Interventions being studied
Behavioral: LungTalk
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • LDCT screening-eligible women who received a BiRADS 1 (negative) or 2 (benign/non-cancerous finding) result from a screening mammogram in the last 7 days
  • Age 50-80 years
  • ≥ 20-pack-year smoking history of combustible cigarettes as per self report
  • Women who currently smoke or quit within past 15 years as per self report
  • Lung screening naïve as per self-report
Reasons someone may not be able to joinExclusion criteria
  • Lung cancer diagnosis
  • Chest CT within the last 12 months

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge, New Jersey
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown, New Jersey
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale, New Jersey
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)Commack, New York
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison, New York
  • Memorial Sloan Kettering Cancer CenterNew York, New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities)Uniondale, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 6, 2026. Always confirm current availability with the study team.

View original record ↗